Investor profile
Brainchild Holdings
Family office
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Brainchild Holdings is the private investment vehicle for Kal Vepuri, managing his personal capital. Since 2009, the firm has pre-seeded or seeded over 250 technology, healthcare, and consumer startups, focusing on transformational companies at the earliest stages. Brainchild targets founders building in B2B software, consumer products, healthtech, fintech, and adjacent sectors primarily in North America, with a typical ticket size under $1 million at the seed stage. The firm has also selectively participated in Series A and growth rounds of breakout companies.
Notable quotes
“I spent half a day with Ben [Silbermann] / Paul [Sciarra] / Yash Nelapati (Pinterest's first engineer) at their condo/office and had a few follow-up discussions. User numbers were early but engagement was high. I won't make that mistake again.”
“Things were going well for me: I was growing Brainchild — my personal holding company. I had seeded some great companies like Warby Parker, Sweetgreen and ClassPass, and I was enjoying my early thirties in New York City. Then my mom got sick — Code Red sick — and things changed pretty dramatically.”
Team
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Artsy (Art.sy) | Later Stage VC | — | 2025-04-24 |
| Bolt | Seed | — | — |
| Gusto | Seed | — | — |
| Oscar Health | Seed | — | — |
| Warby Parker | Seed | — | — |
| Allbirds | Seed | — | — |
| Docker | Seed | — | — |
| Dataminr | Seed | — | — |
| Hero Health | Series A | $12m | 2018-10-16 |
| Sweetgreen | Seed | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| General Catalyst | 3 |
| Founders Fund | 3 |
| Lerer Hippeau | 2 |
| Felicis Ventures | 2 |
| Bessemer Venture Partners | 2 |
| Andreessen Horowitz | 2 |
Fit check
Is Brainchild Holdings a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit